Skip to main content

Julie Ann Woodward

Professor of Ophthalmology
Ophthalmology, Oculofacial Surgery
Box 3802 Med Ctr, Durham, NC
Wadsworth Bldg, Durham, NC

Overview


Julie Woodward, MD is the chief of oculofacial surgery at Duke, She specializes in cosmetic and reconstructive surgery of the eyelids and orbit as well as the cosmetic laser surgery of the skin. Dr. Woodward has published extensively in peer-reviewed journals and several textbooks on cosmetic lasers, injectable fillers, neuromodulators, and benign essential blepharospasm. She speaks frequently at both national and international meetings. In addition, she serves on the editorial board of two aesthetic journals and is the first female oculofacial surgeon to be featured on the cover of the Plastic Surgery Practice Magazine. Dr. Woodward is a passionate artist and works with a variety of mediums. Her work as a cosmetic surgeon is an extension of her great love of art.

Current Appointments & Affiliations


Professor of Ophthalmology · 2021 - Present Ophthalmology, Oculofacial Surgery, Ophthalmology
Chief, Oculoplastics Ophthalmology · 2000 - Present Ophthalmology, Oculofacial Surgery, Ophthalmology
Professor in Dermatology · 2020 - Present Dermatology, Clinical Science Departments

Recent Publications


The Anatomy of Lower Eyelid Fat Pad Vasculature as Found in Lower Eyelid Blepharoplasties.

Journal Article Ophthalmic Plast Reconstr Surg · January 2026 PURPOSE: The vasculature within the lower eyelid fat pads in bilateral lower eyelid blepharoplasty (BLLB) surgery is not well described. Characterization of vasculature may help prevent excessive bleeding by describing the locations where pre-emptive caute ... Full text Link to item Cite

Role of Chemotherapy and Immunotherapy in Advanced T3 or T4 Ocular Surface Squamous Neoplasia: A Review of the Current Literature

Journal Article Current Ophthalmology Reports · December 1, 2025 Purpose of Review: To report on the use of chemotherapy and immunotherapy for advanced T3 or T4 ocular surface squamous neoplasia (OSSN). Recent Findings: Surgical excision has traditionally been the mainstay of treatment for ocular surface squamous neopla ... Full text Cite

Identifying Minimum Single Dose of Recombinant Human Hyaluronidase for In Vitro Dissolution of Twenty-Two Hyaluronic Acid Fillers.

Journal Article Ophthalmic Plast Reconstr Surg · November 2025 PURPOSE: As the use of hyaluronic acid fillers continues to increase for clinical and aesthetic purposes, associated complications continue to rise as well. Excess hyaluronidase is often used to dissolve filler, which has its own set of adverse effects. Th ... Full text Link to item Cite
View All Publications

Recent Grants


Facial and Body Cosmetic Surgery

ConferencePrincipal Investigator · Awarded by American Academy of Cosmetic Surgery · 2016 - 2017

An Anatomical Analysis of the Supratrochlear Vessel and Considerations in Facial Filler Injections

ResearchPrincipal Investigator · Awarded by Valeant Pharmaceuticals International · 2015 - 2017

View All Grants

Education, Training & Certifications


University of Texas Medical School, Houston · 1993 M.D.